# Shares of Sun Pharma rose more than 5% in early trade on Monday after the company announced the acquisition of Organon & Co. The stock was trading at Rs 1,705 on the NSE, up 5.22% in morning deals.

*biotech, business · news · 2026-04-27 · Moneycontrol*

## Key points

- Sun Pharma is acquiring Organon & Co., marking the largest-ever Indian pharma takeover.
- Post-deal, Sun Pharma's leverage will rise to 2.3 times combined EBITDA and debt reduction becomes key.
- The acquisition grants Sun Pharma entry into biosimilars and expands its reach in China and 17 other countries.
- Combined revenue will reach $12.4 billion, with 27% from innovative medicines and 6% from biosimilars.
- Sun Pharma could become debt-free in three to four years, aided by strong combined cash flows.

**Companies:** Sun Pharma
**Countries:** India, China, South Korea, Mexico, Thailand, United States

[Read the full story on Moneycontrol](https://www.moneycontrol.com/news/business/markets/sun-pharma-shares-jump-over-5-after-organon-acquisition-macquarie-sees-debt-free-status-in-3-4-years-13900248.html)

---

Canonical: https://newsio.io/n/a67f7f9d-fad4-423e-aa43-89668d71d9a4/shares-of-sun-pharma-rose-more-than-5-in-early-trade-on-monday-after-the-company
Summarized by Newsio from Moneycontrol. https://newsio.io/how-it-works